The clinical importance of aluminium was fully recognizedin 1976when it was shown that patients with the previously unexplained syndrome known as dialysis dementia had high concentrations of the metal in bone, muscle and brain.' This syndrome had previously been described in groups of patients receivinglong-term haemodialysis to treat chronic renal failure. Subjects would experience symptoms of speech hesitancy at the completion of a dialysis session, which would gradually last for longer periods and subsequently develop into an inability to speak and then into coma and eventually death. Certain dialysis centres were particularly likely to be affected while at others no cases were apparent," Several possible explanations for dialysis dementia were consideredbefore the observations of Alfrey et al. I pointed to the likely role of aluminium. Subsequent work by several groups showed that the probable source of aluminium was the water used to prepare haemodialysis solutions by dilution of concentrates. Drinking water in a few locations has naturally high aluminium concentrations but in many areas that utilize surface water sources, aluminium sulphate is added as part of the treatment process to remove organic contaminants that otherwise colour the water. Water softeners or other relatively simple devices used to treat such water fail to remove much of this aluminium. Later investigations revealed that the aluminium toxicity syndrome also includes anaemia, osteomalacia and ectopic precipitation of calcium.' The realization that aluminium toxicity was a real entity led to the installation of water purification units which work on the principle of reverse osmosis, since which time dialysis dementia has virtually disappeared. However, concern over aluminium toxicity then shifted to a secondary source of exposure-the orally administered aluminium-containing hypophosphataemic agents. Acute toxicity from these materials had been demonstrated in rats in 1972 by Berlyne et al. 3 but such large doses were used in these experiments that they were considered to be irrelevant to humans.I Metabolic balance studies indicated that absorption of aluminium, as the hydroxide, was very poor (less than O· 10/0 at a dose of 2-3 g/day) and that any assimilated was readily excreted in the urine.t-' However, with the removal of dialysis fluid as a source of aluminium, it was evident that patients with chronic renal failure do maintain a significant absorption of aluminium and that in some individuals this, together with reduced urinary elimination, was sufficient to allow accumulation to toxic levels. 6 Recent examples of the sudden onset of neurological symptoms in patients with chronic renal failure who were co-treated with aluminium and citrate?, 8 show that the greater absorption which occurs when the chelate is formed has not always been considered by physicians, even though this effect had been clearly demonstrated by Slanina et al:" and others. Rapid absorption can also be facilitated by changes in the intestinal mucosa with accumulation and encephalopathy.P'!' Exposure to aluminium with the development of signs of toxicity has also occurred from contaminated peritoneal dialysis fluids l 2 and as a consequence of occupational activity.i Various additional sources such as albumin solutions and other fluids for parenteral use, oral baby foods and highly contaminated drinking water have similarly been identified. Serum aluminium concentrations were not increased to the high levels found in dialysis dementia. Nevertheless, accumulation in tissues does occur in some of these situations and should not be overlooked.P:"
Associations between the concentrations of aluminium in drinking water and dementia-related disease have been demonstrated although a causal link is not established." However, a relationship between intake of aluminium and Alzheimer's disease cannot be discounted and work requiring accurate determination of the metal in water, food and biological samples is proceeding.
Therefore, measurement of aluminium in clinical samples is necessary, for:
I. Monitoring patients with chronic renal failure, both those receiving dialysis (as directed by the European Commission) and those with residual functioning kidneys but who receive aluminium orally 2. Observation of patients given intravenous therapy or with occupational exposure, particularly those with reduced renal function 3. Research activities involving the association between aluminium and dementia, mechanisms of intestinal absorption or other projects.
ANALYTICAL REQUIREMENTS
A Resolution of the European Commission16 specifies a series of key concentrations for the control of exposure to aluminium by dialysis patients (Table I) . While these recommendations implicitly contain targets for sensitivity and precision which are the least methods have to meet, in practice analytical demands are much more rigorous. Furthermore, there is discussion as to the validity of some of these recommended levels if net transfer of aluminium into the patient is to be avoided, and clinicians may well elect to work to much stricter guidelines. Concentrations of aluminium in specimens of serum from normal healthy individuals are very much lower than 60 JLg/L (2' 22 JLmollL) and for investigations which include assessments of reference groups, measurements at around 1-5 p.g/L (0 '04-0,18 JLmollL) will be necessary. Although there is reasonable consensus among recent reports as to the reference range it is sometimes suggested that these levels merely represent contamination (see below) and that 'true' levels are considerably lower Y Aluminium in water may also be present at concentrations that range from immeasureably low to in excess of WOO JLg/L (37 JLmoIlL). Table 2 summarizes the concentrations of aluminium typically found in samples of clinical importance. Dialysis concentrates contain very large amounts of electrolytes such as sodium and potassium chloride, sodium acetate, calcium and magnesium, which present a hostile matrix for most analytical techniques. Procedures to overcome interferences must be introduced without sacrifice of sensitivity if accurate results are to be obtained. Tissue specimens have to be pretreated to destroy the organic component and provide a liquid sample for analysis.
Analytical methods require the sensitivity to measure aluminium accurately at concentrations of 1-5 JLg/L (0'04-0·18 JLmoIlL), but should not require excessive sample volume or be slow to TABLEI. carry out. Patients with renal failure are often anaemic and continual removal of large volumes of blood is undesirable. Monitoring the huge numbers of patients with chronic renal failure according to the recommendations of the European Commission16 will require several thousands of measurements per year from each renal unit, and thus the analytical capacity of the laboratory must be extensive. Centralization of analyses to specialist centres provides a number of advantages includinggreater accuracy (see Quality assessment below) and considerable cost savings.
Concentrations specified in European Com

METHODS OF ANALYSIS
Many quantitative analytical techniques have been employed for the measurement of aluminium in water and biological and clinical samples. IS Within the water industry, readily available samples and the relatively simple matrix have historicallyfavoured colorimetric and fluorimetric methods for the measurement of aluminium in water. This inexpensive and simple approach was appropriate for the concentrations of interest (greater than 50 j.lg/L) to the water authorities prior to developments within the last 10 years. 19 For most biological specimens the lower concentrations and smaller available volumes have meant that much more sensitive methods, such as neutron activation analysis and atomic spectrometry, are essential. With attention in recent years focused back on to aluminium in water, these procedures are now also used by water authority laboratories. However, further interest has been shown in the development of fluorimetric and colorimetric agents that provide greater sensitivity and some attempt has been made to apply these to biological samples.
Colorimetric and f1uorimetric analysis
The application of colorimetric and fluorimetric reagents to the determination of aluminium in water has been discussed elsewhere.19,20 Recent experiencewith alternative chromo-and fluorophores such as 2-hydroxy-1-naphthaldehyde-p-methoxybenzoyl hydrazone," or with traditional reagents under revised conditions, for example, Chrome Azurol S, salicylidine-o-aminophenyl, has demonstrated considerable enhancement in sensitivity. Further refinements have included the addition of a detergent to produce increased fluorescence; for example, lO-fold for the aluminium-morin complex. These reagents invariably lack specificity and Fe 3 +, in particular, presents a significant interference. However, this problem can be Measurement 0/ aluminium 379 overcome by inclusion of masking agents which complex with interferents and effectively exclude them from the reaction.
Colorimetric and fluorimetric methods are now appropriate, therefore, for the measurement of aluminium at concentrations of less than 10 j.lg/L (0'4 j.lmol/L) in samples other than water, especially in dialysis concentrates. These latter specimens have not been successfully analysed by atomic absorption procedures without preliminary dilution and loss of sensitivity. We have adapted the Chrome Azurol S colorimetric method for this purpose and also to provide a simple rapid procedure for screening batches of specimen tubes received from manufacturers.P Application of these methods to the measurement of aluminium in samples of serum presents an analytical challenge which a few workers have accepted. lannou and Piperaki" described a kinetic fluorimetric method with a claimed limit of detection of 0·13 j.lg/L (0'05 j.lmol/L) using 1·0 mL of serum, and obtained a good correlation with results given by electrothermal atomic absorption spectrometry (ETAAS). A conventional fluorophore, lumogallion, was employed by Suzuki et al. 22 for an analysis that used at least 1·0 mL of serum. The reported detection limit was 3' 6 j.lg/L (0'13 j.lmol/L). Both methods involved protein precipitation, addition of masking agents and careful control of pH, steps which require continual skilled technical involvement so that staff are not released (as with ET AAS) for other work. The main features, therefore, of colorimetric and fluorimetric methods are:
1. Procedures are available with sensitivity to analyse waters and dialysis fluids 2. Cationic interferences can be overcome by masking agents 3. Methods may be applied to the analysis of serum, but may not offer advantages over ETAAS 4. Procedures require inexpensive reagents and equipment, can be used for large batches, but require much technical time 5. The methods can be applied to screening of sample containers for contamination 6. Methods may be most suitable for the analysis of dialysis concentrates.
Atomic absorption: flame, furnace
The sensitivity afforded by flame atomic absorption spectrometry (FAAS) with a nitrous oxide-acetylene flame is around 0·15 mg/L (5' 56 j.lmol/L) and the method is not suitable, therefore, for the measurement of aluminium in most samples of clinical interest. However, this technique has been used in situations where concentrations were sufficiently high. Aluminium concentrations of O·2-1 . 4 mg/L 7· 4-51 JAlIloIlL) and from O· 12 to 17 800 mg/kg (4' 4 JAlIlollkg-659 mmollkg) were measured in serum and tissue, respectively, from patients with chronic renal failure and from rats given aluminium sulphate by oral or parenteral administration.t-P Progar and May24 included sodium at O·5 mg/L as an ionization suppressant for the FAAS determination of aluminium concentrations in digests of antihaemophilic factor from different suppliers.
No matrix interferences were evident and signal enhancement with butyl alcohol improved the poor recovery initially seen at low concentrations. The procedure of chelation with 8-hydroxyquinoline and extraction at pH 6· 0 into 10 mL of isobutyl methyl ketone was used by Mazzeo and Laurenzi-' to determine aluminium in 200 mL of dialysis fluid concentrate by FAAS. An approximate detection limit of 30/Lg/L (1' 11 /LmoIlL) was thereby achieved and no interferences from the high salt content of the concentrates were found. Plastic containers for haemodialysis solutions were examined to assess whether they may cause contamination of their contents. Samples dissolved in acid and ashed at 800°C were analysed by FAAS and migration of aluminium was shown to occur at pH 2, with prolonged storage and at increased temperature. 26 While there are some situations in which the speed and simplicity of FAAS could be employed for the measurement of aluminium in clinical specimens, these are relatively uncommon and electrothermal atomic absorption spectrometry (ET AAS) is the more usual technique of choice. The following section described various approaches introduced to overcome problems associated with this technique.
The use of ET AAS to achieve rapid, highly sensitive analyses with microlitre sample volumes has been well described" and application of this technique (the limit of determination for aluminium is around 1 /Lg/L, O' 04 /Lmol/L) to measurements in clinical and biological specimens has been regularly reviewed.PThe first reports of ET AAS applied to clinical measurements of aluminium were concerned with analyses of tissue specimens from rabbits and human subjects. 1 , 29, 30 These authors drew attention to the importance of avoiding contamination by extraneous aluminium, a feature that has been emphasized by all subsequent workers. The temperatures chosen for ashing and atomization were similar in these original reports and with only small modifications, have been followed by all other workers so that there have been relatively few variations to the actual heating programme." Further to the analysis of tissue specimens, ETAAS has been applied to the measurement of aluminium in serum, plasma, whole blood, CSF, dialysis fluid, dialysis concentrates, haemofiltration solutions, water and other materials such as pharmaceuticals and foods. While the temperature programmes have not been radically altered there have been many modifications to the other analytical parameters. Changes have been introduced to overcome problems and interferences such as aluminium carbide formation (which inhibits the production of ground state atoms). The diversity of these is particularly evident among the methods described for serum or plasma and were summarized by Berlin et al.;32 1. Tubes of standard electrographite and pyrolitically coated graphite have been recommended.Pi" Others have suggested that pretreatment of the graphite surface with tantalum or zirconium gives longer useful lifetime and improved precision. 34 ,35 The stabilized temperature platform furnace concept (STPF) has been advocated by some authors who use Perkin-Elmer equipment. 17 ,36,3? The STPF concept provides near isothermal conditions during the appearance of ground state atoms and this limits the formation of interfering molecular species. Such interferences are, however, not apparent with all designs of furnace and the STPF approach is not necessarily required. 2. Most workers are agreed that there is little or no non-atomic absorption. 31, [38] [39] [40] however, suggest that for the measurement of aluminium in whole blood at concentrations close to the detection limit there is a very small element of non-atomic absorption. For reasons of security, therefore, some workers elect to include background correction, and both deuterium and Zeeman-effect systems have been used. I? 3. Considerable inventiveness has been applied to sample preparation and 'in-furnace chemistry' (Table 3 ). An important requirement is to displace Cl ' ions to prevent the formation of volatile aluminium chloride which can otherwise be lost prior to the atomization step.
In practice, all that is required is to dilute the specimen with no more than water, nitric acid or a detergent such as Triton X-lOO. 4O Excellent results have been obtained ,with diluents containing these in combination or alone.F-" With many ETAAS methods a matrix modifier, such as magnesium nitrate, is added to samples to reduce the volatility of the analyte and prevent preatornization loss. Slavin'? claims that some aluminium can be lost even at l000°C and recommends the use of a modifier, but this has not been observed by others. Most workers find no loss of aluminium when ash temperatures of 1350°C-1400°C are used. 4. Different methods for calibration have been adopted. While aqueous standards prepared in the appropriate diluent are widely employed, some workers prefer to use matrix-matched standards. A low-aluminium serum specimen is taken and used for dilution of the aqueous aluminium stock standard solution, to prepare working standards. Because of large variations in response reported with uraemic sera, the standards addition procedure which provides for the calibration to be carried out in the sample being assayed, has been strongly advocated." This compensates for variable response but there are disagreements concerning the extent of such interference and conflicting results have been found even when identical methods are used. 17 ,SI Anyone attempting to measure aluminium in serum or plasma should carefully investigate methods for calibration, in all types of specimen, using their own equipment.
Few systematic investigations of the analytical parameters pertinent to measurement of aluminium in serum or plasma are available,17,39,41 These are very helpful to those who use the same equipment but their conclusions are not necessarily relevant to other instrumentation. It is not often recognized that some details of procedures are dependent on the instrument used. Questions of furnace design and graphite quality, which have never really been previously addressed, are discussed below.
With regard to detection, the most sensitive wavelenth is at 309' 3 nm but linearity is lost above working concentrations of approximately 60 ILg/L. To permit the measurement of high concentrations, without repeated dilutions having to be prepared, some workers elect to use the line at 396·2 nm. The choice really depends on whether a large number of samples at high concentrations need to be measured or if most specimens will have aluminium at lower levels. Sensitivity is superior with argon rather than nitrogen as the purge gas. Addition of methane to the purge gas (which decomposes in the furnace to give hydrogen) improved sensitivitySO,S2 and also eliminated spectral interference, attributed to calcium, noted with whole blood. so,s3
These methods are suitable also for the measurement of aluminium in other biological fluids-blood, urine and CSF although a small interference due to iron has been noted with blood specimens.v-t? For samples of waters and dialysis fluids the effects of inorganic components on the formation of aluminium atoms can be abolished by addition of nitric acid to a concentration of 2% V/V. 33,S4 In both these reports it was observed that calibration against aqueous standards was then possible. However, our recent experience with the same instrument has shown that calibration slopes are not the same for dialysis fluid and aqueous solutions. Quantitative recovery and good performance in the external quality control programme were obtained only when a matrixmatched calibration procedure was employed. This observation, together with experience relating to measurement of lead in blood has prompted doubts about consistency in the manufacture of graphite tubes. We have noted a similar poor recovery by many laboratories in the external quality control scheme and suspect that other users of graphite tubes have met with the same experience.
Analysis of dialysis concentrates poses a formidable analytical challenge. The amounts of inorganic solutes are 35-40 fold greater than in blood plasma but dilution of sample to reduce these levels is not a helpful option if the concentrations given in the CEC Resolution-s are to be detected. Analysis of concentrates by ETAAS was accomplished by Starkey et al., 33 Allain et al.,ss Smeyers-Verbeke and Verbeelen," Andersen? and Wolfson and Gracey." Addition of nitric 33.SS or phosphoric" acids, with sample dilution of 1·6 to threefold was one approach while reduction of matrix was achieved with a modifier and L'vov platform together with three-to fourfold dilution. S6,S7 Although these treatments have not allowed for exceptionally good precision or recovery, results are considered acceptable given the very difficult sample matrix.
Although it is rarely mentioned, there are major influences on performance associated with the design and construction of electrothermal furnaces. Factors such as furnace size and flow characteristics of the internal gas affect the rates of temperature increase, formation, dispersion and condensation of atoms, chemical interferences, etc. Therefore, a method developed to give good results with one furnace is unlikely to be useful with other instrumentation without careful evaluation and adaptation by the analyst. In addition, large variations in graphite quality have been observed both within and between batches. Graphite is not merely an inert support" but will contribute to the atomization process and changes in properties will be reflected in the performance of the method. Measurement of aluminium is very sensitive to all these factors and the experience reported by most laboratories with whom we have had contact is that achieving and maintaining a reliable procedure requires individuals who provide care and expertise, and have good understanding of the analytical technique.Pv"
Other methods
Atomic emission spectrometry
Preliminary attempts to measure biological materials were carried out with existing analytical methods such as spark or flame atomic emission spectrometry60-63 with sensitivities approximately 300-3000 less than ETAAS29 and before many of the contamination problems associated with sample collection and preparation were fully appreciated. These methods have now been largely abandoned but other sources for atomic emission spectrometry (AES) have proved successful.
Baxter et at.so developed a constant-temperature graphite furnace and measured aluminium in blood and digested tissues with a detection limit around two-to fourfold better than ET AAS. Instrumentation for electrothermal atomization atomic emission spectrometry has to be constructed by the user but several commercial inductivelycoupled plasma atomic emission spectrometry (ICP-AES) systems are available. Allain ss ,M -66 used ICP-AES to measure aluminium in serum, water and dialysis fluids. Although he achieved excellent results, it is the experience of most workers that the sensitivity is insufficient to determine normal concentrations and that timeconsuming preconcentration steps, with risks of contamination, are necessary."
Inductively coupled plasma-mass spectrometry (ICP-MS)
This can be applied to the measurement of trace elements in biological samples-" but no study of the determination of aluminium has been formally published. The detection limit for aluminium in aqueous solution is reported to be approximately O'6 ng/mL (0' 02 JilllollL)67 although this has been considerably improved by recent developments (Gray, personal communication) . Only a small number of these very expensive instruments are established in laboratories and few are for the analysis of biological samples. Thus, there is little experience to date with the use of ICP-MS for the measurement of aluminium in clinical specimens and while this is likely to develop rapidly in the future the slow analysis rate (20-30 specimens per day) will limit application of the technique to special projects.
Activation analysis
Neutron activation analysis (NAA) is a method that is also too costly and too slow to be considered as the technique of choice for the large number of analytical determinations that are now necessary, and the sensitivity is no better than that obtained by ETAAS. Interferences from other ions have to be eliminated by separation procedures and these add to the complexity of the procedure." However, in the hands of experienced personnel, neutron activation provides an alternative technique for the checking of results, examination of reference materials, etc, and is employed for these purposes. Neutron activation has, however, played a crucial role in understanding the clinical chemistry of aluminium and many important results were obtained by this method. 23.68.69 In seeking to achieve a rational conclusion from a mass of conflicting data relating to reference concentrations, Versieck and Cornelis used neutron activation analysis to demonstrate the most reliable concentrations of aluminium in clinical samples.P Dry ashing, acid digestion, base solubilization and EDTA extraction have all been employed for the preparation of specimens of bone, brain, liver and other tissues. 29 ,45,71 In a comparison of these four methods the most reproducible results were obtained using the simplest procedure, dry ashing." However, if meticulous attention is given to the effective control of contamination, any of these methods should provide acceptable samples for quantitative determination of the total aluminium concentrations. Visualization of aluminium in tissue sections is possible using various histochemical stains" but a range of controls must be set up to detect reactions with other metals. An extremely sensitive and specific semi-quantitative technique to detect aluminium in areas of cells or across a bone biopsy have been developed. Laser microprobe mass analysis (LMMA) is likely to prove to be a very powerful analytical tool in the future."
Methods and analytical performance
No useful evaluation of methods on the basis of analytical performance has been undertaken. The most obvious way to achieve such a comparison would be to examine data from external quality assessment programmes. However, with only one or two exceptions, all participants in these programmes use ETAAS. One laboratory consistently achieves excellent results with an ICP-AES procedure but the limited experience with other methods is more variable and it is impossible Measurement of aluminium 383 to reach general conclusions as to method performance. When external quality assessment data were used to compare the different approaches used for ETAAS, no feature was found to be associated with good (or poor) performance and the most important variable was the laboratory expertisef (see Quality assessment below). The external quality assessment scheme is organized over a succession of 6 month cycles. Three different serum specimens are analysed every month and each cycle includes, therefore, a total of 18 specimens which are prepared from nine pools (each of which is analysed on two separate occasions). From the results reported during a cycle, the performance of each laboratory is determined based on proximity to the consensus median, the difference between the results for samples analysed on two occasions, and the recovery of added aluminium. For each of these, data from a laboratory are plotted on charts such as those shown in Fig. I(a-c) . The outer zone was drawn to include the analytical precision seen to be regularly achieved by specialist laboratories. It was constructed by the organizers of the scheme following discussions with analyst colleagues and is based on considered judgement, not on any calculations. The inner zone has limits which are half of those used for the outer zone. From the number of points within the zones, a 'performance score' is calculated for the laboratory. The maximum possible performance score is 100 and we have proposed that a competent laboratory will obtain a score of at least 70 while lower scores are indicative of poor performance." Although this target is not overly demanding when compared with the criteria used for many other analyses, it is not regularly achieved by many of the participants. This situation is changing, however, and while only 18 and 23 % of participants reached the minimum score in 1986 and 1988, respectively, the figure had increased to 35% in 1990. Examination of data reported by the competent laboratories indicate that between-batch coefficients of variation are around 20% at low concentrations (10 J.lg/L, 0'4 J.lmoIlL) but quickly fall and are approximately 5% at the European Commission target of 60 J.l&!L (2' 2 J.lffioIlL). Other laboratories should aim to match these figures.
Conclusions
For measurement of aluminium in biological samples methods must offer sufficient sensitivity to allow accurate and precise results at
2·0 4·0
Median serum aluminium concentration (~moI/L) concentrations as low as 1-5 J.'g/L (0'04-0'18 J.'mol/L), use less than 0'5 mL of sample, be sufficiently rapid for the analysis of several dozens of specimens per day and be amenable to simple measures to control contamination. Of the methods discussed, ETAAS, NAA, ICP-AES and ICP-MS can provide appropriate sensitivity, but for the practical considerations of sample size, speed of analysis, turnaround time, contamination control and cost, ETAAS is the most suitable. If higher concentrations are expected the alternative methods may be equally appropriate. There are particular difficulties with dialysis concentrates and although ET AAS has been used the results from the external quality assessment scheme" suggest that problems still remain to be overcome. Therefore, by use of larger sample volumes and tolerance of interferences, colorimetric or fluorimetric techniques may be preferable.
PRACTICAL CONSIDERATIONS
Specimens for analysis
Monitoring patients with chronic renal failure for recent exposure to aluminium is best achieved by the measurement of the element in serum or plasma. In subjects with normal renal function this can be supplemented by measurement of the urinary excretion which normally reflects intestinal absorption." However, previous accumulation of aluminium into tissue such as bone cannot be assessed by analysis of these body fluids and even if there is not a large increase in the serum aluminium concentration it cannot be concluded that there is not aluminium toxicity" Aluminium in tissues can be determined indirectly by measurement of the increment in serum concentration following administration of desferrioxarnine. If necessary the desferrioxamine-Al chelate can be measured after extraction'" or after HPLC separation78 or the amount can be derived from the red cell aluminium: serum aluminium ratio.?? Samples of bone can be obtained by iliac biopsy and the total aluminium concentrations measured together with histochemical visualization of the deposition pattern. Concentrations in hair are of little help; there is so much external contamination (which cannot be removed by washing) that any changes in 'endogenous aluminium' are effectively masked even in subjects with gross aluminium overload. Other tissues may be examined after post mortem removal and the brain is the organ of special interest. We can confirm the observations' that concentrations are higher in specific areas of brain and that levels of aluminium are greater in grey matter than in white matter (Table 4) . Dietary intake of aluminium is approximately 2-5 mg per day with further contribution from water ( Table 2 ). If the observations of Martyn et al.l~are substantiated it can be inferred that water aluminium has an exaggerated impact and, therefore, measurement of this dietary source is of special significance. 
Contamination, sample collection and storage
The havoc that can be wrought by external contamination during the analytical procedure has already been emphasized. Equally important, adventitious aluminium must be excluded during the collection and storage of specimens. In an extensive examination of sample tubes it was found 'that glass containers are virtually unusable while those of plastic are very variable in quality. 80 Some suppliers are able to provide tubes that are more or less aluminium-free but it is a wise precaution to check batches before use. Some glass, evacuated blood-collection tubes are specially prepared for trace element specimens and we have found that although these are usually aluminium-free, this cannot be relied upon. More importantly, batches from different factories can be of different quality with respect to contamination and analytical laboratories should always carry out their own, independent assessment. Some Reference Laboratories prefer to issue tubes to blood collection centres and refuse to handle any specimens where they are unsure of the condition of sampling. Except in patients receiving desferrioxamine there is no difference between plasma, red cell and whole blood aluminium concentrationsl" and we often suggest that specimens are sent unseparated to our laboratory so that we can transfer serum to clean specimen tubes. Anticoagulants represent a further contamination source and serum is, therefore, preferred to plasma. Aluminium can be lost from dilute aqueous samples by adsorption on to containers or by other physico-chemical reactions within the solution and acid sould be added to tap water (e.g. to give 1% v/v HN0 3 ) at the time of collection or on receipt by the laboratory. programme organized at Guildford has approximately 120 participants and includes specimens for serum, dialysis fluids, concentrates and water. Results indicate that a relatively small number of participants can regularly achieve an acceptable level of performance (see above) and that almost all of these are specialist trace element reference laboratories. 32
Quality assessment
In an attempt to improve laboratory performance we have prepared serum reference materials in sufficient quantity for these to be used for internal quality control by ourselves and some of our colleagues. Results of preliminary analyses by the users were taken to determine the 'true concentration' or target value and the allowable imprecision or acceptance limits were read from the inner zone of Fig. 1 , at the appropriate concentrations. All laboratories use these specimens with the same target values and acceptance limits, and so have a common internal quality control programme, but the important features of this work are that the limits are tighter than was often previouslyadopted for internal quality control use, that the specimens are regularly re-assayed throughout an analytical run (after a maximum of 10 unknown specimens), and that there is frequent open discussion of external quality assessment performance among the laboratories involved. Instrumental and methodological problems are rapidly detected with this programme and it should be emphasized that the internal quality control specimens are not used to calibrate the procedure. Introduction of this internal quality control programme has not only led to much closer interlaboratory agreement in the external quality assessment programme, as would be expected, but also to improved accuracy because results are nearer to the consensus medians and show better recovery. 83
Laboratories and analytical performance
It is the experience of most laboratories that to obtain good results it is necessary for equipment to be carefully set up, aligned and be in optimal working condition. Careful attention to small detail is required to achieve and maintain these conditions and also to eliminate sources of contamination from within the laboratory. This level of expertise and degree of attention are most likely to be found in a working environment where all staff are consistently faced by such demands, rather than in laboratories with a minor commitment to trace element procedures and where other priorities and skills are needed for the major part of the work carried out.
To our knowledge, competent laboratories are able to measure aluminium in serum, water and dialysis fluids as often as their workload and the constraints of the renal units deem it to be necessary (likely to be at least once a week and probably more often), and without having to repeat many analytical batches because of poor internal quality control results. They adopt a rigorous approach to internal quality control in order to maintain reliable results, and in the external quality assessment scheme their scores are at least equal and often are well in excess of the minimum score of 70 proposed as indicative of good performance.l? Such laboratories inevitably have the skills and experience which produce consistently. good output from their analytical instruments and which are crucial for good performance. Other laboratories with a minor commitment to trace element work appear to find it difficult to establish similar levels of performance.
In addition to their expertise and ability to spot and solve instrumental problems, specialist laboratories will have other equipment to provide backup facilities should a fault develop. Nor are they dependent on a single individual as the only person able to use the equipment. Furthermore, as with any centralization, considerable cost savings can be accomplished. Despatch of specimens and reports via the postal service inevitably extends turnaround times associated with the specialist laboratories but it is unusual for a result to be required urgently and special arrangements can easily be made to cope with such situations when they arise.
SUMMARY
Measurement of aluminium in clinical samples is important for the protection of patients with chronic renal failure, and for investigations of dementia." The types of specimen that need to be analysed include body fluids and tissues, dialysis fluids, water and foods and the concentrations that may be found can range from around 1 ""giL to several mg/L. Although techniques must afford exceptional sensitivity they will also be susceptible to the effects of external contamination and it is imperative that those involved with the analysis, from sample collection through to the determination, ensure that precautions are taken to prevent undue addition of the metal. Of the methods that may be used ETAAS is clearly the most appropriate. Great care is required to achieve reliable performance but with experienced personnel very good results can be obtained.
Regular reviews of recent analytical developments are presented in the Atomic Spectrometry Updates series-" and these are recommended to those who may wish to look for further information.
